The total return over the past 12 months is +2.80% vs. +16.94% for the S&P 500. So far it's up +14.13% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +2.80% | (10.65%) | N/A | N/A | N/A | N/A |
| Total Return CAGR | +2.80% | (10.65%) | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Aura Biosciences, Inc. (AURA)
| Year | Start price | End price | AURA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.45 | $6.22 | +14.13% | +14.51% | (0.38%) |
| 2025 | $8.22 | $5.45 | (33.70%) | +17.72% | (51.42%) |
| 2024 | $8.86 | $8.22 | (7.22%) | +24.89% | (32.11%) |
| 2023 | $10.50 | $8.86 | (15.62%) | +26.19% | (41.81%) |
| 2022 | $16.98 | $10.50 | (38.16%) | (18.17%) | (19.99%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
